Moderated Poster

Poster, Podium & Video Sessions

Moderated Poster

MP12: Stone Disease: Medical & Dietary Therapy

Abstract Presenter(s)

• MA

  Manuel Armas-Phan
• JB

  Joshua Bernard

  Slides  
• 

  Kohldon Boydston, MD,BS

  Duke Division of Urology
• JC

  Julio Chong, MD

  Icahn School of Medicine at Mount Sinai

  Slides  
• MC

  Mariana Coughlin, NONE

  University of Wisconsin-Madison
• JH

  Joel Hancock, MD

  Vanderbilt University

  Slides  
• 

  Kevin Koo, MD, MPH, MPhil

  Johns Hopkins University School of Medicine
• EK

  Eyal Kord, MD

  resident
• TL

  Tim Large
• 

  John Lieske, MD

  Mayo Clinic
• AM

  Anirban Mitra, MD, PHD

  University of Southern California
• 

  Gopal Narang, MD

  University of North Carolina - Chapel Hill

  Slides  
• 

  Caleb Nelson, MD, MPH

  Harvard Medical School
• 

  Andrew Portis, MD
• LP

  Lina Posada, MD

  Universidad de Los Andes

  Slides  
• 

  Maniyur Raghavendran, Sr.

  Apollo Hospitals, Mysore, Karnataka , India
• TS

  Thomas Stout
• NS

  Necole Streeper
• AV

  Annah Vollstedt

Presentations:

• 1:00 PM - 3:00 PM

  Assessment of Surgical Success in Stone Disease: The Patient Perspective
  Gopal Narang, MD
• 1:00 PM - 3:00 PM

  Buyer Beware: Evidence-Based Evaluation of Dietary Supplements for Nephrolithiasis
  Kevin Koo, MD, MPH, MPhil
• 1:00 PM - 3:00 PM

  Dietary Alternatives to Prescription Potassium Citrate
  Tim Large
• 1:00 PM - 3:00 PM

  Dilutional therapy using the vasopressin antagonist tolvaptan for young patients with cystinuria: a pilot investigation
  Caleb P. Nelson, MD, MPH
• 1:00 PM - 3:00 PM

  Effectiveness of Preventative Counseling in Recurrent Stone Formers
  Gopal Narang, MD
• 1:00 PM - 3:00 PM

  Incidence and predictors of repeated and prolonged opioid use after kidney stone diagnosis
  Annah Vollstedt
• 1:00 PM - 3:00 PM

  Is there an app for that? Patient and provider preferences for promoting hydration with mobile phone apps: a strategy for increasing urine volume and decreasing stone risk
  Mariana M. Coughlin, NONE
• 1:00 PM - 3:00 PM

  Kidney stones and risk of narcotic use
  Lina Posada, MD
• 1:00 PM - 3:00 PM

  NEPHROLITHIASIS AND ELEVATED URINARY AMMONIUM: A MATCHED COMPARATIVE STUDY
  Joel Hancock, MD
• 1:00 PM - 3:00 PM

  Protocol to Develop a Digital Biomarker to Detect Drinking Behavior Among Patients with Kidney Stones using Wrist-Worn Inertial Sensors
  Necole Streeper
• 1:00 PM - 3:00 PM

  Racial variations in attitudes of urolithiasis patients towards adopting stone prevention strategies
  Anirban P. Mitra, MD, PHD
• 1:00 PM - 3:00 PM

  Reducing Opiate Use in Emergency Department Management of Acute Renal Colic
  Andrew Portis, MD
• 1:00 PM - 3:00 PM

  Relationship between Daily Water Intake and 24-hour Urine Volume in Adolescents with Kidney Stones
  Joshua Bernard
• 1:00 PM - 3:00 PM

  Risk factors for recurrent infection in patients drained with a DJ stent for ureterolithiasis and sepsis
  Eyal Kord, MD – Assaf Harofe Medical Center
• 1:00 PM - 3:00 PM

  Safety and Efficacy Study of Lumasiran, an Investigational RNA Interference (RNAi) Therapeutic, in Adult and Pediatric Patients with Primary Hyperoxaluria Type 1 (PH1)
  John Charles Lieske, MD – Mayo Clinic, Dept. of Urology
• 1:00 PM - 3:00 PM

  Stent related discomfort- Does adding Mirabgeron to anti cholinergic regimes help?
  Maniyur Raghavendran, Sr.
• 1:00 PM - 3:00 PM

  The Cystinuric Diet’s Impact on Symptomatic Stone Episodes
  Manuel Armas-Phan
• 1:00 PM - 3:00 PM

  THE IMPACT OF ALTERNATIVE ALKALINIZING AGENTS ON 24-HOUR URINE COLLECTION PARAMETERS
  Kohldon C. Boydston, MD,BS – Duke University Medical Center
• 1:00 PM - 3:00 PM

  Uric Acid Supersaturation and Elevated Post Void Residuals are Driving Forces for Uric Acid Bladder Stone Pathogenesis and is Mitigated by Compliance to Urinary Alkalization
  Julio T. Chong, MD
• 1:00 PM - 3:00 PM

  Utilization of a Smart Water Bottle to Increase Fluid Intake in Stone Formers
  Thomas Stout